CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
39 hedge funds and large institutions have $65M invested in Cymabay Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 34 → 39 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
39
Holding in Top 10
3
Calls
$32K
Puts
$3K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$1.1M | |
| 3 | +$980K | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$864K |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$605K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$701K | |
| 3 | -$398K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$129K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$105K |